Inventor · disambiguated record
Timothy D. Connors
Also filed as: CONNORS TIMOTHY · CONNORS TIMOTHY D
14 granted patents·5 pending applications·111 citations·filing 1994–2020
92Inventor score
Top patents by PatentIndex Score
19 records- 0186US6582913B1Diagnostic method for KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Jun 24, 2003·9 cites·16 claims
- 0284US10626169B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2018·Granted Apr 21, 2020·8 cites·17 claims
- 0384US6451534B1KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Sep 17, 2002·8 cites·12 claims
- 0482US6420124B1KVLQT1—a long qt syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Jul 16, 2002·6 cites·7 claims
- 0577US8865870B2Anti-CXCR3 antibodies and methods of use thereofGENZYME CORP·Filed 2013·Granted Oct 21, 2014·5 cites·42 claims
- 0677US6277978B1KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 1998·Granted Aug 21, 2001·18 cites·43 claims
- 0766US6030806AHuman chromosome 16 genes, compositions, methods of making and using sameFiled 1996·Granted Feb 29, 2000·17 cites·25 claims
- 0865US6071717APolycystic kidney disease gene and proteinGENZYME CORP·Filed 1996·Granted Jun 6, 2000·15 cites·23 claims
- 0958US5654170APolycystic kidney disease geneUNIV JOHNS HOPKINS·Filed 1994·Granted Aug 5, 1997·14 cites·9 claims
- 1057US9765144B2Nucleic acids encoding anti-CXCR3 antibodiesGENZYME CORP·Filed 2014·Granted Sep 19, 2017·0 cites·37 claims
- 1156US6972176B2KVLQT1—a long QT syndrome geneGENZYME CORP·Filed 2003·Granted Dec 6, 2005·0 cites·1 claims
- 1254US2019119391A1Anti-cxcr3 antibodies and methods of use thereofGENZYME CORP·Filed 2018·Application pending·0 cites
- 1353US6028173AHuman chromosome 16 genes, compositions, methods of making and using sameGENZYME CORP·Filed 1996·Granted Feb 22, 2000·8 cites·6 claims
- 1451US2018086838A1Anti-cxcr3 antibodies and methods of use thereofGENZYME CORP·Filed 2017·Application pending·0 cites
- 1546US2008044833A1Diagnostic PKM2 methods and compositionsCONNORS TIMOTHY D·Filed 2007·Application pending·0 cites
- 1645US11254737B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2020·Granted Feb 22, 2022·0 cites·38 claims
- 1745US2018214542A1Humanized cxcr3 antibodies with depleting activity and methods of use thereofSANOFI SA·Filed 2017·Application pending·0 cites
- 1840US2018244787A1Anti-human cxcr3 antibodies for treatment of vitiligoSANOFI SA·Filed 2017·Application pending·0 cites
- 1933US6867288B1Polycystic kidney disease geneGENZYME CORP·Filed 1995·Granted Mar 15, 2005·3 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Timothy D. Connors files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →